We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

rs8079416 and 17q12-q21: Asthma and Rhinovirus Susceptibility

rs8079416
Trait
Moderate evidenceGene: 17q12-q21

The rs8079416 variant is located within the 17q12-q21 chromosomal region, a well-studied area associated with childhood-onset asthma. Research suggests this variant may influence how a child's immune system responds to rhinovirus infections, which are common triggers for asthma-related wheezing.

What each genotype means

A/AModerate attention

Lower interferon response

Research indicates that individuals homozygous for the asthma risk allele at this location may exhibit reduced production of interferon-beta in response to certain rhinovirus infections. This genetic profile is associated with a higher susceptibility to viral-induced wheezing in childhood, though it does not guarantee the development of asthma.

Frequency varies significantly by ancestry, and this specific homozygous genotype is more common in populations with higher genetic risk for childhood-onset asthma.

A/GLower attention

Intermediate immune response

Carrying one copy of the asthma risk allele suggests an intermediate profile regarding how your immune system may respond to rhinovirus exposure. While this genotype is linked to the 17q12-q21 risk locus, the clinical impact on your specific immune response is less pronounced than in those who are homozygous for the risk allele.

This heterozygous genotype is commonly observed across diverse populations, though exact frequencies depend on regional and ancestral background.

G/GLower attention

Typical immune response

This genotype represents the non-risk allele at this position, which is not associated with the reduced interferon-beta responses observed in carriers of the risk variant. It is considered the baseline profile in the context of this specific genetic association with rhinovirus-induced wheeze.

This genotype is common in the general population, though its prevalence varies depending on the ancestral composition of the group being studied.

Understanding the 17q12-q21 Locus

The 17q12-q21 region is widely recognized in genomic research as a primary susceptibility locus for childhood-onset asthma. This specific area of chromosome 17 contains several genes that play critical roles in lung development and immune system regulation. Scientists have identified numerous single nucleotide polymorphisms (SNPs) in this region that show consistent statistical associations with asthma phenotypes. Because this locus is highly complex and contains multiple genes, researchers often study specific variants like rs8079416 to better understand how individual genetic differences contribute to the risk of developing respiratory conditions. The region is considered a hotspot for gene-environment interactions, where genetic predisposition meets external triggers like viral infections.

The Role of Rhinovirus in Asthma

Rhinovirus is the most frequent cause of respiratory infections in humans and is a major trigger for asthma exacerbations in children. When a child with asthma is exposed to rhinovirus, the virus can disrupt the integrity of the airway lining, leading to inflammation and increased airway obstruction. Research indicates that the 17q12-q21 locus may harbor mechanisms that are specifically activated or altered during rhinovirus exposure. By studying variants like rs8079416, scientists aim to uncover why some children experience more severe wheezing or airway injury than others when infected. This research is vital for understanding the biological pathways that link viral pathogens to the chronic structural changes observed in the airways of children with asthma.

Evidence and Statistical Associations

The evidence linking rs8079416 to asthma and rhinovirus-induced wheeze is categorized as moderate. Multiple studies have identified this variant through genome-wide association studies (GWAS), which look for patterns of genetic variation that occur more frequently in individuals with a specific trait compared to those without it. While the association is statistically significant in various cohorts, it is important to note that asthma is a polygenic condition, meaning it is influenced by many different genes and environmental factors working in concert. The effect of any single variant like rs8079416 is typically small, and the strength of the association can vary depending on the ancestral background of the population being studied. Current research continues to refine these findings through multi-omics approaches.

Interpreting Your Genetic Information

It is essential to understand that having a specific genotype at the rs8079416 locus does not mean an individual will develop asthma or experience severe reactions to rhinovirus. Genetic associations are based on population-level data and do not provide a diagnostic result for any single person. Asthma is a complex disease managed through clinical evaluation, medical history, and lung function testing. If you or a family member have concerns about asthma symptoms, triggers, or medication management, please consult with a qualified healthcare provider or an asthma specialist. They can provide personalized guidance based on clinical symptoms rather than genetic markers alone. Never use information about genetic variants to make decisions about medical treatments or to alter prescribed asthma therapies.

How common is this variant?

The frequency of the rs8079416 alleles is variable across different global populations and ancestral backgrounds, which is a common characteristic of variants in the 17q12-q21 region.

Frequently asked questions

Does having the rs8079416 variant mean I have asthma?

No. Genetic variants like rs8079416 are associated with a statistical increase in risk within populations, but they are not diagnostic. Asthma is a complex condition diagnosed by doctors based on clinical symptoms and lung function tests.

Can I use this information to change my asthma medication?

No. You should never change your asthma medication or treatment plan based on genetic information. Always discuss your medications and any concerns about your asthma management with your doctor or pharmacist.

Why is the 17q12-q21 region important for asthma?

This region contains several genes involved in immune function and lung development. It is one of the most consistently replicated genetic loci associated with childhood-onset asthma in scientific literature.

Is this variant only found in children?

While the variant is strongly associated with childhood-onset asthma, the genetic markers themselves are present in adults. The research focus is often on children because that is when these specific asthma phenotypes typically emerge.

Sources & further reading

Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs8079416?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in 17q12-q21